venBio Select Advisor »

Tourmaline Bio shares owned by venBio Select Advisor

Quarter-by-quarter ownership of Tourmaline Bio (TRML) shares owned by venBio Select Advisor from 13F filings

Historical chart of venBio Select Advisor investment in Tourmaline Bio

Tip: Access up to 7 years of quarterly data

All positions including Tourmaline Bio held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tourmaline Bio by venBio Select Advisor

Quarter filed Position value Share count Share price at filing
2024-03-31 $51M 2.2M 22.90
2023-12-31 $23M 868k 26.18

More positions owned by venBio Select Advisor

United Therapeutics Corp Common (UTHR)
Apellis Pharmaceuticals Common (APLS)
Ascendis Pharma Sponsored ADR (ASND)
Sarepta Therapeutics Common (SRPT)
Madrigal Pharmaceuticals Common (MDGL)
Argenx Se Sponsored ADR (ARGX)
Krystal Biotech Common (KRYS)
Spdr Series Trust - S&p Biotech Etf (XBI)
Biomarin Pharmaceutical Common (BMRN)
Amicus Therapeutics Common (FOLD)
Cerevel Therapeutics Hldng Common (CERE)
Viking Therapeutics Common (VKTX)
Arrowhead Pharmaceuticals Common (ARWR)
Xenon Pharmaceuticals Common (XENE)
Alpine Immune Sciences Common

View all positions for venBio Select Advisor

Top funds holding Tourmaline Bio

RA Capital Management
BlackRock
BlackRock
Blue Owl Capital Holdings
TCG Crossover Management
Jennison Associates
Vanguard Group
Qiming U.S. Ventures Management
QVT Financial
Nantahala Capital Management
Geode Capital Management
Citadel Advisors
Point72 Asset Management
State Street Corporation
Morgan Stanley

View all funds holding Tourmaline Bio